Profil
Yi Lun Liu is Executive Director at Boyu Capital Group Management Ltd. since 2018 and Non-Executive Director at Keymed Biosciences, Inc. since 2021.
Former roles include Non-Executive Director at Antengene Corp.
Ltd. from 2021 to 2023.
Education includes an undergraduate degree from Fudan University in 2009 and an MBA from Columbia Business School in 2015.
Postes actifs de Yi Lun Liu
| Sociétés | Poste | Début |
|---|---|---|
| KEYMED BIOSCIENCES INC. | Directeur/Membre du Conseil | 03/03/2021 |
Boyu Capital Group Management Ltd. | Directeur/Membre du Conseil | 01/04/2018 |
Anciens postes connus de Yi Lun Liu
| Sociétés | Poste | Fin |
|---|---|---|
| ANTENGENE CORPORATION LIMITED | Directeur/Membre du Conseil | 14/04/2023 |
Formation de Yi Lun Liu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boyu Capital Group Management Ltd. | |
Antengene Corp. Ltd.
Antengene Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes hematologic malignancies therapies | Health Technology |
Keymed Biosciences, Inc.
Keymed Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for the treatment of asthma, chronic obstructive pulmonary and other respiratory diseases | Health Technology |
















